Archive | November, 2009

Cannabinoids in the treatment of cancer.

2009 Nov 18;285(1):6-12. doi: 10.1016/j.canlet.2009.04.005. Epub 2009 May 12. Cannabinoids in the treatment of cancer. Alexander A1, Smith PF, Rosengren RJ. Author information Abstract Cannabinoids, the active components of the hemp plant Cannabis sativa, along with their endogenous counterparts and synthetic derivatives, have elicited anti-cancer effects in many different in vitro and in vivo models of cancer. While the various […]

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer

Mol Cancer Ther. Author manuscript; available in PMC 2014 Aug 11. Published in final edited form as: Mol Cancer Ther. 2009 Nov; 8(11): 3117–3129.  Published online 2009 Nov 3. doi:  10.1158/1535-7163.MCT-09-0448 PMCID: PMC4128286 NIHMSID: NIHMS520388 Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer Zahida Qamri,1,3 Anju Preet,3,4 Mohd W. Nasser,1 Caroline E. Bass,5 Gustavo Leone,2 Sanford H. Barsky,1 and Ramesh K. Ganju1,3 […]

Delta(9)-tetrahydrocannabinol regulates the p53 post-translational modifiers Murine double minute 2 and the Small Ubiquitin MOdifier protein in the rat brain.

2009 Nov 3;583(21):3412-8. doi: 10.1016/j.febslet.2009.09.056. Epub 2009 Oct 9. Delta(9)-tetrahydrocannabinol regulates the p53 post-translational modifiers Murine double minute 2 and the Small Ubiquitin MOdifier protein in the rat brain. Gowran A1, Murphy CE, Campbell VA. Author information  Erratum in FEBS Lett. 2010 Jan 4;584(1):239. Abstract The phytocannabinoid Delta(9)-Tetrahydrocannabinol (Delta(9)-THC), the main psychoactive cannabinoid in cannabis, activates a number of […]